BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28654764)

  • 1. Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis.
    Schiller HB; Mayr CH; Leuschner G; Strunz M; Staab-Weijnitz C; Preisendörfer S; Eckes B; Moinzadeh P; Krieg T; Schwartz DA; Hatz RA; Behr J; Mann M; Eickelberg O
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1298-1310. PubMed ID: 28654764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA.
    Geary B; Sun B; Tilvawala RR; Barasa L; Tsoyi K; Rosas IO; Thompson PR; Ho IC
    Front Immunol; 2023; 14():1290585. PubMed ID: 38094295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.
    Miyagawa-Hayashino A; Yoshifuji H; Kitagori K; Ito S; Oku T; Hirayama Y; Salah A; Nakajima T; Kiso K; Yamada N; Haga H; Tsuruyama T
    Arthritis Res Ther; 2018 Jan; 20(1):13. PubMed ID: 29382365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
    Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
    Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival.
    Fischer A; Swigris JJ; Groshong SD; Cool CD; Sahin H; Lynch DA; Curran-Everett D; Gillis JZ; Meehan RT; Brown KK
    Chest; 2008 Sep; 134(3):601-605. PubMed ID: 18403656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory cytokeratin 17, marginal zone B1 protein and leucine-rich α2-glycoprotein-1 as biomarkers for disease severity and fibrosis in systemic sclerosis patients.
    Bălănescu P; Bălănescu E; Băicuș C; Bălănescu A
    Biochem Med (Zagreb); 2022 Oct; 32(3):030707. PubMed ID: 36277429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.
    Martyanov V; Kim GJ; Hayes W; Du S; Ganguly BJ; Sy O; Lee SK; Bogatkevich GS; Schieven GL; Schiopu E; Marangoni RG; Goldin J; Whitfield ML; Varga J
    PLoS One; 2017; 12(11):e0187580. PubMed ID: 29121645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.
    Hoffmann-Vold AM; Weigt SS; Saggar R; Palchevskiy V; Volkmann ER; Liang LL; Ross D; Ardehali A; Lynch JP; Belperio JA
    EBioMedicine; 2019 Dec; 50():379-386. PubMed ID: 31732480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
    Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
    BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.
    Storme M; Semionov A; Assayag D; Lefson M; Kitty D; Dannenbaum D; Torrie J; Lejeune P; Robinson E; Ahmad Khan F
    PLoS One; 2017; 12(9):e0184548. PubMed ID: 28886193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
    Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
    Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
    Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
    Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
    PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.